Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
54 participants
OBSERVATIONAL
2022-01-21
2023-02-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of the LMA Supreme When Inserted With Patients in the Prone Position
NCT03633942
Blind Tracheal Intubation Through Supraglottic Airway Devices
NCT05624073
Fibre-optic Guided Tracheal Intubation Through SADs
NCT03118596
Comparison of Various Supraglottic Airway Devices for Fiberoptical Guided Tracheal Intubation
NCT02501577
the Effective Bolus Dose of Remifentanil for Laryngeal Mask Airway (LMA) Insertion in Children
NCT01919203
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Laryngeal Mask Airway
Airway and Ventilation
Insertion of Laryngeal Mask airway for ventilation or use of Face Mask
Face Mask
Airway and Ventilation
Insertion of Laryngeal Mask airway for ventilation or use of Face Mask
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Airway and Ventilation
Insertion of Laryngeal Mask airway for ventilation or use of Face Mask
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients willing to participate and provide an informed consent.
* Patients scheduled to undergo an elective surgical procedure including laparoscopic or robotic that requires GETA.
Exclusion Criteria
* Patients with history of uncontrolled GERD.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klaus D. Torp
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Klaus Torp, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic Florida
Jacksonville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-008655
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.